Takaki Komiya
Mishima, 6188585, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Rapid and Robust Multi-Phenotypic Assay System for ALS Using Human iPS Cells with Mutations in Causative Genes.
Journal: International journal of molecular sciences
Published: February 27, 2023
Sphingosine 1-Phosphate Receptor Modulator ONO-4641 Regulates Trafficking of T Lymphocytes and Hematopoietic Stem Cells and Alleviates Immune-Mediated Aplastic Anemia in a Mouse Model.
Journal: The Journal of pharmacology and experimental therapeutics
Published: August 09, 2020
Differential Effects of 2-Hydroxypropyl-Cyclodextrins on Lipid Accumulation in Npc1-Null Cells.
Journal: International journal of molecular sciences
Published: December 24, 2019
Discovery of a 1-Methyl-3,4-dihydronaphthalene-Based Sphingosine-1-Phosphate (S1P) Receptor Agonist Ceralifimod (ONO-4641). A S1P1 and S1P5 Selective Agonist for the Treatment of Autoimmune Diseases.
Journal: Journal of medicinal chemistry
Published: November 10, 2017
Sphingosine 1-phosphate receptor modulator ONO-4641 stimulates CD11b+Gr-1+ cell expansion and inhibits lymphocyte infiltration in the lungs to ameliorate murine pulmonary emphysema.
Journal: Mucosal immunology
Published: November 01, 2017
A sphingosine 1-phosphate receptor agonist ameliorates animal model of vasculitis.
Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]
Published: February 12, 2016
Suppressive effects of a novel CC chemokine receptor 4 antagonist on Th2 cell trafficking in ligand- and antigen-induced mouse models.
Journal: European journal of pharmacology
Published: June 12, 2013
Efficacy and immunomodulatory actions of ONO-4641, a novel selective agonist for sphingosine 1-phosphate receptors 1 and 5, in preclinical models of multiple sclerosis.
Journal: Clinical and experimental immunology
Published: August 20, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026